Literature DB >> 1384223

Small cell carcinoma of the ovary: an immunohistochemical and ultrastructural study with a review of the literature.

B Lifschitz-Mercer1, R David, M Dharan, B Czernobilsky.   

Abstract

This is an immunohistochemical and ultrastructural study of two small cell carcinomas of the ovary with a review of the literature. These cases showed a dimorphic population of small and large cells sharply demarcated from each other. Cytokeratin 18 and vimentin were mainly expressed in the large tumour cells, some of which also stained for alpha-smooth muscle actin. Periodic-acid-Schiff-positive, alpha-1-antitrypsin-positive hyaline globules were present in one case. Ultrastructural findings included filamentous nucleolonema as well as evidence of smooth muscle differentiation. Some of these observations have not been previously reported. Certain of the above features seem to support a germ cell origin of small cell carcinoma, but they cannot be considered specific for germ cell neoplasms. Thus, small cell carcinoma of the ovary cannot be classified into one of the known categories of ovarian tumours at the present time.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384223     DOI: 10.1007/bf01611184

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  14 in total

1.  Small cell carcinoma of the ovary that is commonly associated with hypercalcemia is a neuroendocrine tumor on the basis of presently available evidence.

Authors:  R E Scully; G R Dickersin
Journal:  Int J Gynecol Pathol       Date:  1989       Impact factor: 2.762

2.  Spermatocytic seminoma. II. Ultrastructural study.

Authors:  J Rosai; K Khodadoust; I Silber
Journal:  Cancer       Date:  1969-07       Impact factor: 6.860

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Poorly differentiated (small cell) carcinoma of the ovary in young women: evidence supporting a germ cell origin.

Authors:  T M Ulbright; L M Roth; F B Stehman; A Talerman; E K Senekjian
Journal:  Hum Pathol       Date:  1987-02       Impact factor: 3.466

5.  Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings.

Authors:  P Aguirre; A D Thor; R E Scully
Journal:  Am J Clin Pathol       Date:  1989-08       Impact factor: 2.493

6.  Ultrastructural analysis of small cell carcinomas of the ovary.

Authors:  J T McMahon; W R Hart
Journal:  Am J Clin Pathol       Date:  1988-11       Impact factor: 2.493

7.  Paraneoplastic hypercalcemia in ovarian tumors.

Authors:  G Holtz; T R Johnson; M E Schrock
Journal:  Obstet Gynecol       Date:  1979-10       Impact factor: 7.661

8.  Cytokeratins of normal epithelia and some neoplasms of the female genital tract.

Authors:  R Moll; R Levy; B Czernobilsky; P Hohlweg-Majert; G Dallenbach-Hellweg; W W Franke
Journal:  Lab Invest       Date:  1983-11       Impact factor: 5.662

9.  Alpha-fetoprotein, alpha-1-antitrypsin, and transferrin in gonadal yolk-sac tumours.

Authors:  J O Beilby; C H Horne; G D Milne; C Parkinson
Journal:  J Clin Pathol       Date:  1979-05       Impact factor: 3.411

10.  Small cell carcinoma of the ovary. A report of six cases.

Authors:  V Abeler; K E Kjørstad; J M Nesland
Journal:  Int J Gynecol Pathol       Date:  1988       Impact factor: 2.762

View more
  2 in total

1.  Small Cell Ovarian Carcinomas - Characterisation of Two Rare Tumor Entities.

Authors:  K Münstedt; R Estel; T Dreyer; A Kurata; A Benz
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-07       Impact factor: 2.915

2.  Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.

Authors:  Christina E Hoei-Hansen; Sigrid M Kraggerud; Vera M Abeler; Janne Kaern; Ewa Rajpert-De Meyts; Ragnhild A Lothe
Journal:  Mol Cancer       Date:  2007-02-02       Impact factor: 27.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.